Blog10 March 2021 Castor Inks Big Pharma Deal As Decentralized Trials Business Continues to Show Exponential Growth Hoboken, New Jersey: March 10, 2021: Castor, a leading provider of clinical trial technology, today announced the signing... Learn more
White papers & guides26 January 2021 A Guide to Capturing and Managing Data in Digital Therapeutics Trials This playbook is a tool for sponsors and CROs who want to leverage DCT technology to support remote... Learn more
Blog12 January 2021 Why Remote Consent Is the New Normal in 2021 COVID-19 changed the conversation around enrollment and recruitment for clinical trials. Learn how eConsent is helping researchers do... Learn more
Blog17 December 2020 Castor Launches Scalable Decentralized Trial Platform After 383% Commercial Growth Hoboken, New Jersey: December 17, 2020: Castor, a leading provider of clinical trial technology, today announced the launch... Learn more
Blog14 December 2020 Top 4 eConsent Questions from Clinical Researchers In September 2020, Castor CEO Derk Arts, MD, Ph.D., led a webinar on electronic informed consent (eConsent) challenges... Learn more
Blog8 December 2020 Castor Expands Advisory Board to Support US Growth of Decentralized Clinical Trial Platform Industry veterans from leading life sciences companies including Johnson & Johnson, Biogen, and Medtronic, will support the Company’s... Learn more
White papers & guides30 November 2020 eBook: The Decentralized Clinical Trial Playbook This playbook is a tool for sponsors and CROs who want to leverage DCT technology to support remote... Learn more
Blog12 November 2020 Decentralized Trial Tech Strategy In Three Steps Though technologies that support decentralized clinical trials (DCT) have been readily available for years, meaningful industry adoption has... Learn more
Webinar Research Continuity During COVID-19 Watch this webinar for tips on how to ensure research continuity during COVID-19 by running your trial with... Learn more
Blog5 October 2020 Common shortcomings of clinical research data for PMCF The following is an excerpt from our free whitepaper ‘Satisfying PMCF requirements by utilizing IIS data’. Click here... Learn more
Blog5 October 2020 Castor is now live in Australia! To support our growing customer base in the APAC region, we established new hosting in Australia. By allowing... Learn more
Webinar eConsent – The Enrollment Solution for Decentralized Trials Join this webinar to understand how eConsent works, where it falls in the regulatory guidelines & see a... Learn more
Blog31 August 2020 Castor Announces Partnership With Click Therapeutics to Support Decentralized Clinical Trials Hoboken, New Jersey: September 2, 2020: Castor, a leading provider of clinical trial technology that automates the research... Learn more
Blog19 August 2020 Castor Raises a $12M Series A to Further Their Support for COVID-19 Research With 4,000 live studies and 2M enrolled patients across 90 countries, Castor will use the funding to further... Learn more
Webinar An Expert Panel on Decentralized and Hybrid Trials, Pre and Post COVID-19 The world may have changed seemingly overnight, but clinical research and medical innovation must continue now more than... Learn more
Blog29 July 2020 What Will Trial Enrollment & Engagement Look Like in a Socially-Distanced World? When the COVID-19 pandemic began, the industry needed to focus immediately on research continuity and determine how to... Learn more
White papers & guides14 July 2020 Using Decentralized Trial Technology to Ensure Study Continuity and Data Quality During COVID-19 and Beyond Download this white paper to learn why patient-centric, remote research technologies such as eConsent, EDC, and ePRO are... Learn more
Blog16 June 2020 Protocol Deviations in Clinical Trials: Understanding the FDA’s Guidance Protocol deviations can seriously impact the integrity of clinical trials, and with regulatory scrutiny growing, it’s crucial to... Learn more
